Proprietary AI analyst is now available
- Public Comps
- Dr.Finance
Dr.Finance Valuation Multiples
Discover revenue and EBITDA valuation multiples for Dr.Finance and similar public comparables like Wierzyciel, Ditix, One Solution, Ventana Global and more.
Dr.Finance Overview
About Dr.Finance
Dr.Finance SA is a financial intermediary in the sale of loans and other financial products. It operates in the business of Working capital loans, Investment loans, Leasing, and Factoring.
Founded
2008
HQ

Employees
2
Website
Sectors
Financials (FY)
EV
$1M
Valuation Multiples
Start free trialDr.Finance Financials
Dr.Finance reported last fiscal year revenue of $1M and negative EBITDA of ($76K).
In the same fiscal year, Dr.Finance generated $1M in gross profit, ($76K) in EBITDA losses, and had net loss of ($57K).
Dr.Finance P&L
In the most recent fiscal year, Dr.Finance reported revenue of $1M and EBITDA of ($76K).
Dr.Finance is unprofitable as of last fiscal year, with gross margin of 96%, EBITDA margin of (6%), and net margin of (5%).
Financial data powered by Morningstar, Inc.
Dr.Finance Stock Performance
Dr.Finance has current market cap of $1M, and enterprise value of $1M.
Market Cap Evolution
Dr.Finance's stock price is $0.39.
Dr.Finance share price decreased by 10.6% in the last 30 days, and increased by 72.3% in the last year.
Dr.Finance has an EPS (earnings per share) of $-0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1M | $1M | -6.4% | -10.6% | 23.3% | 72.3% | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDr.Finance Valuation Multiples
Dr.Finance trades at 1.2x EV/Revenue multiple, and (19.0x) EV/EBITDA.
Dr.Finance Financial Valuation Multiples
As of June 6, 2026, Dr.Finance has market cap of $1M and EV of $1M.
Dr.Finance has a P/E ratio of (25.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Dr.Finance Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Dr.Finance Margins & Growth Rates
In the most recent fiscal year, Dr.Finance reported gross margin of 96%, EBITDA margin of (6%), and net margin of (5%).
Dr.Finance Margins
Dr.Finance Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Dr.Finance Operational KPIs
Dr.Finance's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.6M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Dr.Finance Competitors
Dr.Finance competitors include Wierzyciel, Ditix, One Solution, Ventana Global, LexBono, Akcept Finance, Femion Technology, Atlantis, Marka and PBS Finanse.
Most Dr.Finance public comparables operate across Specialty Finance.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.3x | - | (42.8x) | - | |||
| 16.3x | - | 102.0x | - | |||
| 1.7x | - | 19.7x | - | |||
| - | - | - | - | |||
| 3.2x | - | 160.5x | - | |||
| 72.9x | - | (16.2x) | - | |||
| (1.5x) | - | 43.7x | - | |||
| 5.5x | - | 5.9x | - | |||
This data is available for Pro users. Sign up to see all Dr.Finance competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Dr.Finance
| When was Dr.Finance founded? | Dr.Finance was founded in 2008. |
| Where is Dr.Finance headquartered? | Dr.Finance is headquartered in Poland. |
| How many employees does Dr.Finance have? | As of today, Dr.Finance has over 2 employees. |
| Is Dr.Finance publicly listed? | Yes, Dr.Finance is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Dr.Finance? | Dr.Finance trades under DRF ticker. |
| When did Dr.Finance go public? | Dr.Finance went public in 2008. |
| Who are competitors of Dr.Finance? | Dr.Finance main competitors include Wierzyciel, Ditix, One Solution, Ventana Global, LexBono, Akcept Finance, Femion Technology, Atlantis, Marka, PBS Finanse. |
| What is the current market cap of Dr.Finance? | Dr.Finance's current market cap is $1M. |
| What is the current revenue of Dr.Finance? | Dr.Finance's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Dr.Finance? | Current revenue multiple of Dr.Finance is 1.2x. |
| Is Dr.Finance profitable? | No, Dr.Finance is not profitable. |
| How many companies Dr.Finance has acquired to date? | Dr.Finance hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Dr.Finance has invested to date? | Dr.Finance hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Dr.Finance
Lists including Dr.Finance
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.